期刊文献+

帕洛诺司琼在肿瘤化疗中的合理应用与效果研究

下载PDF
导出
摘要 将我院收治的56例恶性肿瘤患者随机分为观察组和对照组,观察组患者使用盐酸帕洛诺司琼,对照组患者使用盐酸格拉司琼,比较两组恶心、呕吐发生情况以及用药不良反应。结果两组患者急性恶心、呕吐发生情况比较差异无统计学意义(P>0.05);观察组延迟性恶心、呕吐发生情况明显优于对照组,差异具有显著性(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。帕洛诺司琼防治肿瘤化疗引起的恶心、呕吐临床效果显著,不良反应少,安全性高,应用价值较高。
作者 官炜
出处 《现代诊断与治疗》 CAS 2013年第18期4149-4149,共1页 Modern Diagnosis and Treatment
  • 相关文献

参考文献4

二级参考文献36

  • 1赵忠斌,魏振平,芮伟.化疗止吐临床治疗药物新进展[J].世界临床药物,2006,27(8):480-484. 被引量:35
  • 2陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:47
  • 3董洪敏,金风,黄薇,陈海霞,欧阳伟伟,姜汉.恩丹西酮、格拉司琼、托烷司琼预防化疗呕吐的比较[J].贵阳医学院学报,2007,32(3):264-266. 被引量:11
  • 4Hesketh P J.Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting[J].Cancer Invest,2000,18(2):163.
  • 5Coates A,Abraham S,Kaye S B,et al.On the receiving end-patient perception of the side-effects of cancer chemotherapy[J].Eur J Cancer Clin Oncol,1983,19(2):203.
  • 6Dewan P,Singhal S,Harit D.Management of chemotherapy-induced nausea and vomiting[J].Indian Pediatr,2010,47(2):149.
  • 7Navari R M.Pathogenesis based treatment of chemotherapy induced nausea and vomiting two new agents[J].J Support Oncol,2003,1(2):89.
  • 8Bloechl-Daum B,Deuson R R,Mavros P,et al.Delayed nausea and vomiting continue to reduce patients′ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment[J].J Clin Oncol,2006,24(27):4472.
  • 9Kaiser R,Sezer O,Papies A,et al.Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes[J].J Clin Oncol,2002,20(12):2805.
  • 10Grunberg S M,Dugan M,Muss H,et al.Effectiveness of a single-day three-drug regimen of dexamethasone,palonosetron,and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy[J].Support Care Cancer,2009,17(5):589.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部